11 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

EIUS UNICOMPARTMENTAL KNEE SYSTEM

FDA 510(k)
FDA Class 2 ·Orthopedic

SOLIDEA

FDA UDI
CALZIFICIO PINELLI SRL·08300496033769·PERSONALITY 140 SHEER, SIZE 1XXL, CAMEL, GRADUA...

Baltic Denture System BDLoad

FDA UDI
Merz Dental GmbH·D7091033769·Baltic Denture System BDLoad BDLoad ↓ Mm6 PLSEu...

ENCORE MICROPTIC POWDER FREE LATEX SURGICAL GLOVES, MODEL 87

FDA 510(k)
FDA Class 1 ·General, Plastic Surgery

V-GNATHOS SUPRA

FDA 510(k)
FDA Class 2 ·Dental

SMALL POSTERIOR AUGMENT GLENOID PLATE, RIGHT

FDA Adverse Event
Injury ·EXACTECH, INC.·Product code KWS·October 10, 2022

ACCU-CHEK ® MULTICLIX

FDA Adverse Event
Malfunction ·ROCHE DIAGNOSTICS·Product code FMK·April 3, 2013

UNKNOWN DEPUY ASR HIP

FDA Adverse Event
Injury ·DEPUY INTERNATIONAL, LTD.·Product code KWA·March 17, 2011

DEXTRUS 4137

FDA Adverse Event
Injury ·BIOTRONIK GMBH AND CO.·Product code DTB·April 25, 2008

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

Smiths Medical Medfusion Model 4000 Syringe pump, Item Numbers: a) 4000-0101-249, b) 4000-0101-50, c) 4000-0101-51, d) 4000-0105-249, e) 4000-0105-50, f) 4000-0105-51, g) 4000-0105-78, h) 4000-0106-00, i) 4000-0106-01, j) 4000-0106-231,

FDA Enforcement
Class II ·Ongoing·Smiths Medical ASD Inc.·April 24, 2024